Author Archives: Lu Rahman

#Immuno-oncology #Immunotherapy #Mouse models

Taconic Biosciences expands immuno-oncology animal model portfolio

Taconic Biosciences, global provider of drug discovery animal model solutions, has expanded its immuno-oncology portfolio. Immuno-oncology is a leading research priority because it uses the body’s own immune system to effectively treat some types of cancer. Syngeneic tumour animal models play a critical role because they use standard inbred mice… Read More

#Cancer Research #News

#DNA #Drug discovery #Lead optimisation #Screening

X-Chem acquires IntelliSyn and AviSyn to boost drug discovery service

X-Chem, provider of DNA-Encoded Library (DEL)-based discovery services, has acquired IntelliSyn, a Montreal-based drug discovery services company and its US-based sister company, AviSyn. The transaction will enable the company to offer a complete, seamless solution for screening, hit validation and lead optimisation on existing and new markets. Financial details of… Read More

#News

#Events #Immunology / Virology & Vaccines #RNA

RNA Anti-Infectives Symposium

Two weeks ago, the Moderna mRNA vaccine became the third vaccine to be approved for emergency use in the UK. With 94% effectiveness, this vaccine is an exciting addition to the COVID-19 relief effort and brings us one step closer to the end of the pandemic. Before 2020, efforts to study mRNA vaccines… Read More

#Editor's Choice #News

#Immunotherapy #Oncology

Genetic changes in tumours could help predict if patients will respond to immunotherapy

Researchers at the Francis Crick Institute, the UCL Cancer Institute, and the Cancer Research UK Lung Cancer Centre of Excellence have identified genetic changes in tumours which could be used to predict if immunotherapy drugs would be effective in individual patients. Immunotherapies have led to huge progress treating certain types… Read More

#Cancer Research #Editor's Choice #News #Trending News

#High content imaging #SLAS 2021

Molecular Devices next-generation imaging system with deep learning technology

Molecular Devices, provider of high-performance life science technology, has globally launched its next-generation, high-content imaging system. The ImageXpress Confocal HT.ai High-Content Imaging System is designed to help researchers advance phenotypic screening of 3D organoid models. The new system is designed to offer faster image acquisition and multiplexing flexibility with high-performance… Read More

#News

#Biopharmaceuticals #Biotherapeutics

Genedata and IDBS partnership streamlines biopharma discovery and development

Genedata and IDBS, have entered into a strategic partnership to create synergies between their platforms. The combined solution will directly integrate IDBS digital solutions with the Genedata Biopharma Platform so that all R&D as well as manufacturing data can be seamlessly exchanged, processed, and interpreted along the entire biopharma workflow. Read More

#News

#Covid-19 #Flow Cytometry #Immunology / Virology & Vaccines

DDW App Note: The ZE5 Cell Analyzer in the fight against COVID-19

This paid-for app note by Bio-Rad appeared in DDW Volume 22, Issue 1 – Winter 2020/21. As COVID-19 has taken the world by storm, much has been learnt about the various aspects of viral infections ranging from immune surveillance to the therapeutic development of vaccines. One of the technologies that has… Read More

#Exclusive Content

#Covid-19 #Immunology / Virology & Vaccines

Moderna vaccine protective against UK and South African variants

Moderna has released results from in vitro neutralisation studies of sera from individuals vaccinated with its COVID-19 vaccine showing activity against emerging strains of SARS-CoV-2. Vaccination with the Moderna COVID-19 vaccine produced neutralising titers against all key emerging variants tested, including B.1.1.7 and B.1.351, first identified in the UK and… Read More

#News #Trending News